Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 21 % of short-term debt in 2025; threshold 65 %.
-
Legal situation KBO
Gerechtelijke ontbinding of nietigheid according to the CBE.
Financials
Financial year 2025
JORELIE SOINS INFIRMIERS from Charleroi, company number BE0779717078, closed financial year 2025 with a result of € 817 after tax. For that financial year JORELIE SOINS INFIRMIERS recorded a gross margin of € 30,929 and equity of € 19,957. Compared with financial year 2024, the result moved from € -43,197 to € 817. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 19,957
▲ 4% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 817
▲ still € 43,197 loss in 2024
Profit after tax over the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 14,957.
People and assets in 2025
€ 6,545
▼ 11% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 564,253
▲ 1% vs 2024
€ 63,503 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.
€ 5,282
▲ 300% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 5,542
▲ 1% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 76,778 | € 61,697 | € 19,188 | € 30,929 | ▲ 61% |
| Profit after taxes | € 49,603 | € 7,735 | € -43,197 | € 817 | ▲ € 44,014 |
| Equity | € 54,603 | € 62,338 | € 19,140 | € 19,957 | ▲ 4% |
| Total debts | € 54,965 | € 662,258 | € 587,108 | € 577,996 | ▼ 2% |
| Cash | € 106,193 | € 108,225 | - | - | |
| Land & buildings | - | € 598,881 | € 589,532 | € 566,956 | ▼ 4% |
| Retained profit | € 49,603 | € 57,338 | € 14,140 | € 14,957 | ▲ 6% |
| Bank debt | € 0 | € 585,587 | € 559,841 | € 564,253 | ▲ 1% |
| Balance sheet total | € 109,568 | € 724,596 | € 606,249 | € 597,953 | ▼ 1% |
Key figures of JORELIE SOINS INFIRMIERS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to JORELIE SOINS INFIRMIERS?
What happened at JORELIE SOINS INFIRMIERS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
JORELIE SOINS INFIRMIERS is active according to the CBE. Legal situation: Gerechtelijke ontbinding of nietigheid.
- New annual accounts for financial year 2025: profit of € 817. filed late Source: NBB ↗
- Karl De Ridder became a director. NBB
- New establishment in Charleroi. KBO
- Start of the company according to the CBE. KBO
In short
From € 49,603 profit in 2022 to € 817 profit in 2025.
Paid € 25,021 in corporate taxes since 2022.
Best year ever: 2022, with € 49,603 profit.
A new publication or filing at JORELIE SOINS INFIRMIERS? We notify you, reason included.
Follow JORELIE SOINS INFIRMIERSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind JORELIE SOINS INFIRMIERS is Karl De Ridder. Karl De Ridder is also behind Marketing Gestion Communication, BETONS BATIMENTS ET MANUTENTION, JORELIE REMPLACEMENTS INFIRMIERS and FUNERAILLES JONCKERS.
Directors
According to the 2025 annual accounts
Karl De Ridder
Director
Also active at: Marketing Gestion Communication, BETONS BATIMENTS ET MANUTENTION, JORELIE REMPLACEMENTS INFIRMIERS, FUNERAILLES JONCKERS
since 2025
Establishments
Establishment units
Physical locations of this company
Rue Sart-les-Moulins 118-001
6044 Charleroi
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0779.717.078
- VAT number
- BE 0779.717.078
- Registered office
- Rue Sart-les-Moulins 118-001, 6044 Charleroi
- Names & denominations
- JORELIE SOINS INFIRMIERS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Gerechtelijke ontbinding of nietigheid
- Start date
- 5 January 2022
- Peppol
- Not registered